Ad Hoc Announcement Pursuant to Art.?53 LR Geneva, Switzerland, January 7, 2026 - Addex Therapeutics(SIX: ADXN and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing ...

The prototype uses a Canon EOS R10 with a Dual Pixel CMOS sensor, which allows every pixel to participate in phase detection.

As of Wednesday, January 07, CytomX Therapeutics, Inc.’s CTMX share price has surged by 6.40%, which has investors questioning if this is right time to sell.

Austin Ryan Lauless, known online as “Cason Fredrickson” or “APOPHIS,” pleaded guilty in September to 13 counts of sexual exploitation of a child, five counts of sex trafficking of a minor, two counts ...

The field of cancer treatment saw a variety of advancements in 2025, from new dedicated centers to approved treatments to ...

Researchers from Carnegie Mellon University's College of Engineering have proposed a new photography method that eliminates the need to choose between focusing on the foreground, midground, ...

Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company developing innovative medicines for unmet ...

Corcept Therapeutics CORT announced that the FDA has issued a complete response letter (“CRL”) to its new drug application ...

Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the ...

Lucid Group, Inc. , maker of the world's most advanced electric vehicles, today announced that the Lucid Gravity SUV has been recognized by the MotorTrend Best Tech Awards for delivering the Best ...

MarketsandMarkets forecasts the sector will expand at 38.6% annually through 2030 [3], driven by chronic disease burden and data explosion. The FDA cleared over 1,250 AI-enabled medical devices by mid ...